Analysts have been eager to weigh in on the Healthcare sector with new ratings on Acutus Medical (AFIB) and Glaukos (GKOS).
Acutus Medical (AFIB)
In a report released today, Marie Thibault from BTIG maintained a Buy rating on Acutus Medical, with a price target of $40.00. The company’s shares closed last Tuesday at $34.00.
According to TipRanks.com, Thibault is a 5-star analyst with an average return of 73.7% and a 71.8% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Varian Medical Systems, and Edwards Lifesciences.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Acutus Medical with a $35.00 average price target.
See today’s analyst top recommended stocks >>
Glaukos (GKOS)
In a report released today, Ryan Zimmerman from BTIG maintained a Hold rating on Glaukos. The company’s shares closed last Tuesday at $77.99, close to its 52-week high of $79.50.
According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of 22.5% and a 63.7% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Staar Surgical Company, and Zimmer Biomet Holdings.
The word on The Street in general, suggests a Hold analyst consensus rating for Glaukos with a $70.75 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
